The Premier Consulting Blog

OCTOBER 21, 2024

However, accelerated approval comes with a condition: sponsors must conduct confirmatory trials to verify the drug’s anticipated clinical benefits using robust outcome measures. Concerns have arisen over delays—sometimes spanning over 7–8 years—that may expose patients to risks before confirmatory trials are completed.

Trials 52

Trials FDA Clinical Trials Disease 52

PPD

JULY 13, 2023

Site and patient recruitment vendors are vital in supporting clinical trial operations across all phases and therapeutic areas. Their services help engage a suitable participant pool, facilitate clinical trial participation, ensure that selected sites have the resources to support clinical trial activities and more.

Clinical Trials 52

Clinical Trials Pharma Companies Trials Clinical Research 52

The Pharma Data

SEPTEMBER 24, 2020

UK-headquartered company will characterise autoantibody profiles of clinical trial patients. Nottingham, UK-headquartered Oncimmune has signed a collaboration with Roche’s Genentech division to profile samples from the latter’s rheumatology clinical trials.

Trials 40

Trials Clinical Trials Pharma Companies Disease 40

The Pharma Data

OCTOBER 16, 2020

As pharma companies search for solutions to avoid cancelling or delaying clinical trials, virtualizing trials are fast becoming commonplace during the Covid-19 pandemic. With many nationwide and regional lockdowns coming into force, virtual clinical trials are proving to be an effective way to monitor patients remotely.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Clinical Research 52

The Pharma Data

DECEMBER 21, 2020

The trial will be conducted at 10 sites across Germany and led by principal investigator Prof. The FOCUS trial is Ultimovacs’ fourth Phase II clinical trial with UV1 and comes in addition to the collaboration Phase II trial announced in May 2020. “We Mascha Binder, M.D.,

Vaccine 52

Vaccine Trials Clinical Trials Clinical Development 52

DrugBank

JUNE 27, 2024

Add to that, these drugs have already passed safety tests, meaning they could potentially move through early-phase trials faster if doses are compatible for new uses. These include matching molecular signatures, virtual screening, and analyzing large datasets from health records and clinical trials.

Drugs 71

Drugs Pharma Companies Clinical Trials Computational Chemistry 71

DrugBaron

JANUARY 31, 2024

Billions of dollars have been invested in companies promising to “revolutionise pharma R&D” through the application of artificial intelligence – but it is now clear that global pharma companies, and not just tech bro’s, are buying into the claims. And there is no doubt that there is plenty of room for improvement.

Pharma R&D 165

Pharma R&D Science Small Molecule Drugs 165

Reprocell

NOVEMBER 1, 2022

Pharma companies are legally required to test novel drugs in animal models before beginning human trials. And while animal testing has progressed thousands of therapeutics that we use today, it is not without its experimental and ethical downfalls.

Animal Testing 52

Animal Testing Pharma Companies Laboratories Drug Development 52

DrugBaron

OCTOBER 17, 2022

Examples, such as post-hoc analyses of failed trials, are today too numerous to even be notorious. In practice, this looks much more like a traditional pharma company than a biotech. Pharma companies, unlike most biotechs, actually sell something – and they are usually phenomenally good at it.

Pharma Companies 100

Pharma Companies Pharmaceuticals Drug Development Production 100

The Pharma Data

SEPTEMBER 29, 2020

. Sosei Heptares has received a $5m milestone payment from its strategic alliance partner Pfizer after the first subject in a clinical trial was dosed with a new drug candidate from the collaboration between the two companies.

Structure Based Drug Design (SBDD) 52

Structure Based Drug Design (SBDD) Clinical Trials Small Molecule Pharma Companies 52

The Pharma Data

DECEMBER 23, 2020

Eligible patients enrolled in the trial receive treatment with AIM’s flagship pipeline drug Ampligen. The Ampligen EAP protocol is authorized to enroll up to 100 active trial participants, 20 of whom may be Long Haulers. development pipeline for ME/CFS. All study subjects will receive the same Ampligen treatments. AIM ImmunoTech Inc.

Clinical Trials 52

Clinical Trials Trials Virus Therapies 52

H1 Blog

JULY 30, 2024

Increasing diversity in clinical trials not only makes the findings more relevant to various patient groups, but also enhances knowledge about the disease or medical product being studied. We’re curious to see what will happen over the next 12 months and how pharma companies will respond.”

FDA 59

FDA Clinical Trials Compliance Pharma Companies 59

biobide

FEBRUARY 2, 2024

This is why not many Pharma companies specifically specialize in discovering and developing pediatric cancer treatments; a great example of advancing new therapies for childhood cancer is the biotech Oncoheroes.

Disease 59

Disease Medical Schools Pharma Companies Clinical Trials 59

The Pharma Data

SEPTEMBER 14, 2020

Supply chain uncertainty is a challenge every clinical supply chain manager wrestles with – stemming from increasing product demand and quality, the growing complexity of clinical trial designs and a lack of visibility in the supply chain. Accelerating your clinical trial supply through digitalization.

Clinical Supply 52

Clinical Supply Clinical Trials Pharma Companies Trials 52

Drug Target Review

MARCH 15, 2024

Cultural differences between the UK and mainland Europe were still quite different then but we settled in Southampton and I later went to University in Brighton, studied for a D.Phil, and found a job at a Pharma company. Do you have any challenges as a woman in STEM?

Organic Chemistry 59

Organic Chemistry Pharma Companies Clinical Trials Pharmaceuticals 59

The Pharma Data

SEPTEMBER 11, 2020

In an effort to slow the spread of the disease and prevent a second wave, pharma companies around the world are continuously looking to advance new methods of treatment. This week’s round up dives into developments from companies based in Australia and the US. Saama Technologies, Inc. , Source link.

Clinical Trials 52

Clinical Trials Pharma Companies Trials Hospitals 52

Metabolite Tales Blog

DECEMBER 19, 2023

Metabolite Bioanalysis in Drug Development: Recommendations from the IQ Consortium Metabolite Bioanalysis Working Group A Metabolite Bioanalysis Working Group comprised of experts from 14 different pharma companies have proposed recommendations around best practice in metabolite bioanalysis during drug development.

Pharma Companies 52

Pharma Companies Drug Development Trials Compliance 52

H1 Blog

JUNE 26, 2024

In a recent interview, Daniel Perez, the Director and Global Head of Health Equity for Worldwide Clinical Trials shared insights on health equity from personal and professional experiences. Perez spoke about the opportunities and challenges in health equity and the role of pharma companies and CROs to drive more equitable research.

Clinical Trials 59

Clinical Trials Trials FDA Pharma Companies 59

Quanticate

OCTOBER 16, 2020

Gathering all the heterogenous data and mapping to the internal standards of the pharma companies proved to be the greatest challenge of the time. Until 2007, the Food Drug & Administration (FDA) and the biopharmaceutical industry were grappled by the non-standardized sources of data.

Pharma Companies 52

Pharma Companies FDA International Drugs 52

Codon

FEBRUARY 13, 2024

1 Yet even after more than two decades of research, media hype, and dozens of clinical trials and biotech start-ups that have come and gone, phage therapy has not scaled. No phage-based therapeutic has reached the latter stages of the clinical trial pipeline (where promising results lead to an expanded trial involving thousands of patients).

Therapies 124

Therapies Virus DNA Clinical Trials 124

H1 Blog

JULY 5, 2023

The success of drug development and approval relies heavily on the ability to identify diverse patient populations for clinical trials. From trial site feasibility to successful trial recruitment, diversity within a trial population helps ensure the safety and efficacy of drugs that reach the market. African Americans).

Clinical Trials 52

Clinical Trials Drugs Trials Drug Development 52

Drug Patent Watch

JANUARY 9, 2025

The pharmaceutical landscape is evolving rapidly, with small and medium-sized biotech companies increasingly taking center stage in innovation. In 2017, small and medium-sized biotech companies accounted for 51% of FDA market approvals, while large pharma companies were the originators in only 28% of approvals[4].

Compliance 52

Compliance Drug Development Therapies Pharma Companies 52

The Pharma Data

OCTOBER 20, 2020

In hopes to advance the best and brightest, MD Anderson, in partnership with The Focus Fund GP, has launched the Cancer Focus Fund to propel compelling investigational cancer therapies from preclinical development through Phase II clinical trials. The fund is already starting off with more than $50 million in initial capital. .

Clinical Trials 52

Clinical Trials Therapies Pharma Companies Trials 52

Sygnature Discovery

DECEMBER 22, 2022

Sygnature Discovery joins four of the top ten global pharma companies, Cancer Research Horizons , Manchester Cancer Research Centre (MCRC) and over 20 Contract Research Organisations (CROs) to support innovation in oncology through the second Oncology Development Programme (ODP2).

Pharma Companies 52

Pharma Companies Clinical Trials Science Trials 52

Sygnature Discovery

DECEMBER 22, 2022

Sygnature Discovery joins four of the top ten global pharma companies, Cancer Research Horizons , Manchester Cancer Research Centre (MCRC) and over 20 Contract Research Organisations (CROs) to support innovation in oncology through the second Oncology Development Programme (ODP2).

Pharma Companies 52

Pharma Companies Clinical Trials Science Trials 52

ACTO

NOVEMBER 25, 2024

“Our ambition is to become the first pharma company powered by artificial intelligence at scale, giving our people tools and technologies that focus on insights and allow them to make better everyday decisions. … The Perceptron was designed to improve the accuracy of computer predictions.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Pharmaceuticals 52

The Pharma Data

JANUARY 17, 2021

This week another biopharma announced the disappointing news that their trial too had failed to make an impact on the devastating progression of Alzheimer’s. Nonetheless, the company plans to advance the drug to a full Phase III program with a larger sample size and a higher-dose arm. . Glutamate dysfunction is a feature of AD.

Pharma Companies 52

Pharma Companies Disease Treatment Trials 52

Vial

MARCH 1, 2024

Growth factors for this market included the growing size of the pharmaceutical industry, the increasing number of clinical trials , substantial funds dedicated to pharma and biotech R&D, and the growing biosimilars and generics market. By geographical region, the global CRO services market in 2023 was dominated by North America.

Clinical Trials 52

Clinical Trials Clinical Research Trials Laboratories 52

Vial

DECEMBER 8, 2023

In this article by Vial CRO (Contract Research Organization), we will explore five anticipated ophthalmology therapies in 2024, offering valuable insights for biotech startups, CROs, pharma companies, clinical sites, and scientists planning to conduct clinical trials.

Therapies 52

Therapies Clinical Trials Trials Treatment 52

The Pharma Data

DECEMBER 4, 2020

Following a worldwide Phase 3 trial of BNT162b2 and results indicating the vaccine to be more than 90 per cent effective in preventing Covid-19 cases where participants have shown no evidence of being infected with coronavirus , Pfizer and BioNTech are anticipating further regulatory decisions and approvals to be made around the world.

Vaccine 52

Vaccine Pharma Companies Science Trials 52

The Pharma Data

NOVEMBER 9, 2020

The Phase 3 trial is continuing to enroll and is expected to continue through the final analysis when a total of 164 confirmed Covid-19 cases have been accrued. The first set of results from our Phase 3 Covid-19 vaccine trial provides the initial evidence of our vaccine’s ability to prevent Covid-19. “We

Vaccine 52

Vaccine Pharma Companies Science Trials 52

Advarra

JUNE 14, 2022

Often, low accrual or delays in clinical trials stem from an undersized pipeline of potential participants. When site staff must manually find participants for trials, or even when automated recruitment solutions don’t deliver as promised, it puts the trial’s viability at stake, with sites and sponsors in the hot seat.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Research 52

The Open Targets Blog

OCTOBER 24, 2023

Several key publications have shown that medicines with genetic evidence to support the link between target and disease have a higher chance of success in clinical trials, especially phase II safety trials.  Why did you decide to share this openly?

Bioinformatics 63

Bioinformatics Packaging Pharmaceutical Companies Pharma Companies 63

H1 Blog

MAY 10, 2023

Nurses, Treatment Leaders & A New Brand of KOL In addition to their frontline roles in patient care, nurses are increasingly serving as key opinion leaders (KOLs) for pharma companies on new treatments and medicines – leveraging their expertise on the latest developments in healthcare research and clinical trials.

Nurses 52

Nurses Doctors Pharma Companies Clinical Trials 52

Predictive Oncology

FEBRUARY 7, 2023

“We’re providing that richness of tumor diversity and the population diversity that normally the companies will not be able to see until they are in a clinical trial and [the drug is] challenged against a multitude of different patients.”

Clinical Trials 52

Clinical Trials Pharmaceutical Companies Trials Pharmaceuticals 52

The Pharma Data

DECEMBER 11, 2020

The University of Oxford has regularly appeared in our updates since July 2020, as its team of researchers leads an ongoing clinical trial for the Covid-19 vaccine. More recently, the university has released news of its collaboration with Thermo Fisher Scientific as it looks to discover an immune Covid-19 response pre- and post-vaccination.

Vaccine 52

Vaccine Immune Response Pharma Companies Virus 52

The Pharma Data

NOVEMBER 27, 2020

This week, another pharma company revealed a new technology device that can detect if a patient is infectious or not, while the Russian government published results of its Sputnik V vaccine, claiming it is more than 95 per cent efficient 42 days after the first dose.

Virus 52

Virus Vaccine International Immune Response 52